India Healthcare: Growth Survived; Margin Did Not Fully Follow
Revenue and profit are healthy, but negative margin change keeps the sector quality-gated.
The prior note is marked to the substantially loaded Q1 tape. Growth justifies exposure; conversion determines position size. The exhibit separates aggregate, median, sub-industry and coverage evidence.
Executive Summary
On one aligned company cohort, Q1 revenue grew +17.3%, EBITDA grew +10.8% and PAT grew +7.9%; operating margin changed -1.30pp. The same-store aggregate compares with median-company revenue of +17.4% and median PAT of +18.5%. The Q1 FY2027 revenue-loaded coverage set contains 247 companies, or 92.2% of the sector's 268 classified names. Those reporters represented 94.7% of all loaded Q1 FY2026 revenue for that fixed universe. This is loaded analytical coverage, not regulatory filing completeness.
Members only
Continue reading with Aurific
The full note — snapshot, sector trends, evidence checklist, decision rules and watch list — is available to Aurific members. Sign in to keep reading, or request access.